Enrique Soto-Pedre
Overview
Explore the profile of Enrique Soto-Pedre including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
40
Citations
216
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Petty L, Soto-Pedre E, McCrimmon R, Pearson E
J Diabetes Complications
. 2024 Apr;
38(6):108747.
PMID: 38643555
Information on BMI and risk of developing hypertension in type 1 diabetes (T1D) is scarce, and it comes mostly from cross-sectional analyses. This study underscores a risk of developing hypertension...
2.
Sterenborg R, Steinbrenner I, Li Y, Bujnis M, Naito T, Marouli E, et al.
Nat Commun
. 2024 Jan;
15(1):888.
PMID: 38291025
To date only a fraction of the genetic footprint of thyroid function has been clarified. We report a genome-wide association study meta-analysis of thyroid function in up to 271,040 individuals...
3.
Soto-Pedre E, Newey P, Leese G
J Clin Endocrinol Metab
. 2023 Apr;
108(10):e1117-e1124.
PMID: 37022975
Context: Previous studies, including our own, have demonstrated a highly variable incidence of primary hyperparathyroidism (PHPT) from year to year. Objective: We planned to provide a current estimate of the...
4.
Dalgard Dunvald A, Nielsen F, Olsen D, Ernst M, Donnelly L, Soto-Pedre E, et al.
Br J Clin Pharmacol
. 2023 Mar;
89(8):2529-2541.
PMID: 36967527
Aims: Drug metabolism might be altered in patients with type 2 diabetes. We aimed to evaluate if initiation of glucose-lowering drugs impacts warfarin efficacy and drug metabolism. Methods: First, we...
5.
Soto-Pedre E, Lin Y, Soto-Hernaez J, Newey P, Leese G
J Clin Endocrinol Metab
. 2023 Feb;
108(9):e842-e849.
PMID: 36810667
Context: Primary hyperparathyroidism (PHPT) is associated with increased risk of morbidity and death, and vitamin D levels are a potentially confounding variable. Objective: The aim of this study was to...
6.
Soto-Pedre E, Newey P, Srinivasan S, Siddiqui M, Palmer C, Leese G
J Clin Endocrinol Metab
. 2022 Sep;
107(12):3302-3308.
PMID: 36102151
Context: A hypothesis-free genetic association analysis has not been reported for patients with primary hyperparathyroidism (PHPT). Objective: We aimed to investigate genetic associations with PHPT using both genome-wide association study...
7.
Soto-Pedre E, Siddiqui M, Mordi I, Maroteau C, Soto-Hernaez J, Palmer C, et al.
Eur Thyroid J
. 2021 Dec;
10(6):439-446.
PMID: 34950598
Objective: We aimed to validate the association of genome-wide association study (GWAS)-identified loci and polygenic risk score with serum thyroid-stimulating hormone (TSH) concentrations and the diagnosis of hypothyroidism. Then, the...
8.
Siddiqui M, Smith G, St Jean P, Dawed A, Bell S, Soto-Pedre E, et al.
Diabetologia
. 2021 Sep;
65(1):101-112.
PMID: 34562103
Aims/hypothesis: Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity has an independent prognostic association with major coronary events (MCE). However, no study has investigated whether type 2 diabetes status modifies the effect of...
9.
Soto-Pedre E, Siddiqui M, Maroteau C, Dawed A, Doney A, Palmer C, et al.
Front Genet
. 2021 Jul;
12():652878.
PMID: 34249083
Aims: Atrial fibrillation (AF) is a risk for patients receiving thyroid hormone replacement therapy. No published work has focused on pharmacogenetics relevant to thyroid dysfunction and AF risk. We aimed...
10.
Leese G, Soto-Pedre E
Clin Endocrinol (Oxf)
. 2021 May;
95(4):574-575.
PMID: 33990990
No abstract available.